RELATIONSHIP BETWEEN C-ERBB-2 IMMUNOREACTIVITY AND THYMIDINE LABELING INDEX IN BREAST-CARCINOMA INSITU

被引:48
|
作者
BARNES, DM
MEYER, JS
GONZALEZ, JG
GULLICK, WJ
MILLIS, RR
机构
[1] ST LUKES HOSP,CHESTERFIELD,MO
[2] JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110
[4] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,MOLEC ONCOL GRP,LONDON W12 0HS,ENGLAND
关键词
C-ERBB-2; IMMUNOHISTOCHEMISTRY; THYMIDINE LABELING INDEX; BREAST CARCINOMA INSITU;
D O I
10.1007/BF01975438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between the presence of the c-erbB-2 protein, demonstrated immunohistochemically with antibody 21N, and thymidine labelling index (TLI) has been studied in the in situ component of 70 cases of carcinoma of the breast. A significant association was found between high TLI and positive staining. Twenty of the 70 cases stained (29%) and of those that were stained 75% had a high TLI; 43% of those with a high TLI stained positively but only 14% of those with a low TLI stained positively. Strong correlations were seen between nuclear size and histological pattern and both 21N staining and TLI. The majority of carcinomas of comedo pattern with large nuclei were 21N positive and had a high TLI, whilst those with small nuclei and a predominantly cribriform/micropapillary appearance did not stain and had a low TLI. In tumours of mixed histological pattern there was less concordance between staining and TLI. The significance of these findings in relation to the biological behaviour of these tumours and their clinical management is discussed.
引用
下载
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [21] PREDICTION OF EARLY COURSE OF BREAST-CARCINOMA BY THYMIDINE LABELING
    MEYER, JS
    FRIEDMAN, E
    MCCRATE, MM
    BAUER, WC
    CANCER, 1983, 51 (10) : 1879 - 1886
  • [22] THYMIDINE LABELING INDEX V FLOW CYTOMETRIC DNA MEASUREMENTS FOR PROGNOSIS OF BREAST-CARCINOMA
    MEYER, JS
    PREY, MU
    CELL AND TISSUE KINETICS, 1987, 20 (06): : 638 - 638
  • [23] INSITU DISTRIBUTION OF ONCOGENE PRODUCTS AND GROWTH-FACTOR RECEPTORS IN BREAST-CARCINOMA - C-ERBB-2 ONCOPROTEIN, EGFR, AND PDGFR-BETA-SUBUNIT
    KOMMOSS, F
    COLLEY, M
    HART, CE
    FRANKLIN, WA
    MOLECULAR AND CELLULAR PROBES, 1990, 4 (01) : 11 - 23
  • [24] IMMUNOHISTOCHEMICAL LOCALIZATION OF C-ERBB-2 IMMUNOREACTIVITY IN BENIGN AND MALIGNANT BREAST DISEASE
    MACHIN, LG
    GULLICK, WJ
    GIBBS, NM
    POWLES, TJ
    HARRISON, S
    GUSTERSON, BA
    JOURNAL OF PATHOLOGY, 1988, 154 (01): : A43 - A43
  • [25] IMMUNOHISTOCHEMICAL DISTRIBUTION OF C-ERBB-2 IN INFILTRATING AND INSITU BREAST-CANCER
    GUSTERSON, BA
    MACHIN, LG
    GULLICK, WJ
    GIBBS, NM
    POWLES, TJ
    PRICE, P
    MCKINNA, A
    HARRISON, S
    INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (06) : 842 - 845
  • [26] C-ERBB-2 ONCOGENE PROTEIN IN INSITU AND INVASIVE LOBULAR BREAST NEOPLASIA
    PORTER, PL
    GARCIA, R
    MOE, R
    CORWIN, DJ
    GOWN, AM
    CANCER, 1991, 68 (02) : 331 - 334
  • [27] ABSENCE OF C-ERBB-2 IMMUNOSTAINING IN HISTOLOGICAL TYPES OF INVASIVE BREAST-CARCINOMA KNOWN TO HAVE A GOOD PROGNOSIS
    SOOMRO, S
    SHOUSHA, S
    TAYLOR, P
    SHEPARD, M
    JOURNAL OF PATHOLOGY, 1990, 161 (04): : A358 - A358
  • [28] Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis
    Ferrero-Poüs, M
    Hacène, K
    Bouchet, C
    Le Doussal, V
    Tubiana-Hulin, M
    Spyratos, F
    CLINICAL CANCER RESEARCH, 2000, 6 (12) : 4745 - 4754
  • [29] CORRELATION BETWEEN HISTOLOGIC GRADE OF MALIGNANCY AND COPY NUMBER OF C-ERBB-2 GENE IN BREAST-CARCINOMA - A RETROSPECTIVE ANALYSIS OF 176 CASES
    TSUDA, H
    HIROHASHI, S
    SHIMOSATO, Y
    HIROTA, T
    TSUGANE, S
    WATANABE, S
    TERADA, M
    YAMAMOTO, H
    CANCER, 1990, 65 (08) : 1794 - 1800
  • [30] IMMUNOHISTOCHEMICAL EVALUATION OF C-ERBB-2 ONCOGENE EXPRESSION IN DUCTAL CARCINOMA INSITU AND ATYPICAL DUCTAL HYPERPLASIA OF THE BREAST
    LODATO, R
    MAGUIRE, H
    GREENE, M
    WEINER, D
    LIVOLSI, V
    LABORATORY INVESTIGATION, 1990, 62 (01) : A59 - A59